Budget Impact Analysis of First-Line Treatment with Branded Pemetrexed (ALIMTA) for Advanced Non-Squamous Non-Small Cell Lung Cancer in China
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2142
https://www.valueinhealthjournal.com/article/S1098-3015(16)33508-2/fulltext
Title :
Budget Impact Analysis of First-Line Treatment with Branded Pemetrexed (ALIMTA) for Advanced Non-Squamous Non-Small Cell Lung Cancer in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33508-2&doi=10.1016/j.jval.2016.09.2142
First page :
A720
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2030